Low-density lipoprotein receptor–related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas-Reference-Cited by-同舟云学术

Low-density lipoprotein receptor–related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas

Published:2011-11 Issue:11 Volume:42 Page:1581-1588
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Catasus Lluis,Gallardo Alberto,Llorente-Cortes Vicenta,Escuin Daniel,Muñoz Josefina,Tibau Ariadna,Peiro Gloria,Barnadas Agusti,Lerma Enrique

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference44 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Invasive breast carcinoma;Ellis,2003

3. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up;Elston;Histopathology,1991

4. Gene-expression signatures in breast cancer;Sotiriou;N Engl J Med,2009

5. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci USA,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer;International Journal of Biological Sciences;2024

2. The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape;Cell Communication and Signaling;2023-06-27

3. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors;Scientific Reports;2023-06-02

4. Insights into Overlapping of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis;Iranian Journal of Allergy, Asthma and Immunology;2023-05-13

5. Correlations between serum lipid and Ki‑67 levels in different breast cancer molecular subcategories;Oncology Letters;2022-12-20